AGT and heart failure: In this context, as previously mentioned, the lncRNA cardiac hypertrophy-related factor (CHRF) is upregulated in vivo in response to angiotensin II (Ang II) treatment and it is increased in human tissue from patients with heart failure (Wang et al., 2014b).